Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Venessa Chin"'
Publikováno v:
Public Health Research & Practice, Vol 34, Iss 3 (2024)
Objectives: The coronavirus disease 2019 (COVID-19) pandemic disrupted healthcare systems worldwide, causing substantial changes to routine healthcare delivery. National and international modelling studies have predicted adverse impacts of this disru
Externí odkaz:
https://doaj.org/article/b38b786ba3d243ddaa3e4d238b00000e
Autor:
Malinda Itchins, BMedSci, M.B.B.S., FRACP, PhD, Shirley Liang, BSc, Chris Brown, MBiostats, BSc, Tristan Barnes, BSc (Med), M.B.B.S., FRACP, Gavin Marx, BSc, M.B.B.S., FRACP, Venessa Chin, M.B.B.S., FRACP, PhD, Steven Kao, BHB, MBChB, PhD, FRACP, Po Yee Yip, MBChB, FRACP, PhD, Antony J. Mersiades, BMedSc, M.B.B.S., FRACP, MMed (Clin. Epi), Adnan Nagrial, M.B.B.S., FRACP, PhD, Victoria Bray, M.B.B.S., FRACP, PhD, Geoffrey Peters, BPharm, M.B.B.S., FRACP, Sagun Parakh, BSc, MBChB, FRACP, PhD, Kavita Garg, PhD, Bob T. Li, MD, PhD, MPH, Matthew McKay, PhD, Kenneth O'Byrne, M.B.B.S., FRACP, FRCPA, MD, Thomas John, M.B.B.S., FRACP, PhD, Anthony J. Gill, MD, FRCPA, Mark P. Molloy, PhD, Benjamin J. Solomon, M.B.B.S., FRACP, PhD, Nick Pavlakis, BSc, M.B.B.S., MMed (Clin. Epi), PhD, FRACP
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 9, Pp 100703- (2024)
Introduction: ALK-positive lung cancers represent a molecularly diverse disease. With drug exposure, driving selection pressure, and resistance pathways, disease relapse will emerge. There is compelling rationale to investigate novel treatment strate
Externí odkaz:
https://doaj.org/article/c4d94b5682fa4f42ad7cf98e2bbfcd9a
Autor:
Chris Brown, Wendy Cooper, Amy O’Donnell, John Simes, Davinia Seah, Michael Boyer, Jane Young, Karen Briscoe, Ruth Jones, David Barnes, Brian McCaughan, Venessa Chin, Bea Brown, Kirsty Galpin, Diane McPhail
Publikováno v:
BMJ Open, Vol 14, Iss 2 (2024)
Objectives Lung cancer continues to be the most common cause of cancer-related death and the leading cause of morbidity and burden of disease across Australia. There is an ongoing need to identify and reduce unwarranted clinical variation that may co
Externí odkaz:
https://doaj.org/article/33a58655e04245b09b564b78d7ad053d
Publikováno v:
Cancer Medicine, Vol 12, Iss 10, Pp 11234-11247 (2023)
Abstract Background Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) require multi‐modality treatment. Immune checkpoint inhibitors (ICIs) are now standard of care in management of recurrent/metastatic HNSCC. However, it
Externí odkaz:
https://doaj.org/article/3d266d38ea8d48ad995b88f61c670e77
Autor:
Yiran Zhang, Kelly Curtis, Lanjia Lin, John Park, Douglas Adkins, A Dimitrios Colevas, Natalie Rainey, Bruno Fang, Minh Phan, Katie Kerrigan, Venessa Chin, Diogo Alpuim Costa, José Dinis, Siu-Chi Chang Sun, Michael Howland
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/7aa15cf15277499fba361e2075238edb
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 116-123 (2023)
Thymic tumours are rare thoracic malignancies with thymic carcinoma accounting for approximately 12% of all thymic tumours compared to thymomas which account for approximately 86%. Unlike thymomas, it is very rare for thymic carcinomas to be associat
Externí odkaz:
https://doaj.org/article/2526f8df0060473dbb11f8179c9a5ed3
Autor:
Diar Aziz, Christine Lee, Venessa Chin, Kristine J Fernandez, Zoe Phan, kConFab Investigators, AOCS Study Group, Paul Waring, C Elizabeth Caldon
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 8, Iss 4, Pp 355-370 (2022)
Abstract Basal‐like breast cancer (BLBC) has a greater overlap in molecular features with high‐grade serous ovarian cancer (HGSOC) than with other breast cancer subtypes. Similarities include BRCA1 mutation, high frequency of TP53 mutation, and a
Externí odkaz:
https://doaj.org/article/a5b727e7474c49bbb67d277f89421abf
Autor:
Jennifer Lim, Alexander Murphy, Stephen Wong, Adnan Nagrial, Deme Karikios, Dariush Daneshvar, Rachael McCloy, Angela M Steinmann, Sandra O'Toole, Venessa Chin
Publikováno v:
Cancer Treatment and Research Communications, Vol 32, Iss , Pp 100576- (2022)
Background: Despite advances in immunotherapy and targeted therapy, platinum-based chemotherapy remains crucial for many patients with advanced non-small cell lung cancer (NSCLC). Resistance to platinum chemotherapy is common, and predictive biomarke
Externí odkaz:
https://doaj.org/article/c6f6f9eabdb24cf0bd7313e48f9a0c34
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2019)
Durvalumab is a programmed cell death ligand 1 inhibitor, which is now approved in Australia for use in non-small-cell lung and urothelial cancers. Autoimmune diabetes is a rare immune-related adverse effect associated with the use of immune checkpoi
Externí odkaz:
https://doaj.org/article/8fd5086b1ed24af4959b423ad0821ffc
Autor:
Alvaro Gonzalez Rajal, Kamila A Marzec, Rachael A McCloy, Max Nobis, Venessa Chin, Jordan F Hastings, Kaitao Lai, Marina Kennerson, William E Hughes, Vijesh Vaghjiani, Paul Timpson, Jason E Cain, D Neil Watkins, David R Croucher, Andrew Burgess
Publikováno v:
eLife, Vol 10 (2021)
We previously used a pulse-based in vitro assay to unveil targetable signalling pathways associated with innate cisplatin resistance in lung adenocarcinoma (Hastings et al., 2020). Here, we advanced this model system and identified a non-genetic mech
Externí odkaz:
https://doaj.org/article/2218265a2a26450eb03d27ef3e339032